Targeting CFTR: how to treat cystic fibrosis by CFTR-repairing therapies.

Abstract excerpt

Several novel compounds recently appeared as promising leads to develop effective drugs against the basic defect in Cystic fibrosis (CF) and the first rationale therapies for CF relying on the understanding of the basic defect started to hit the clinical setting. Most of these efforts are focused on correcting the F508del mutation (occurring in ≈90% of CF patients) which causes misfolding of the CF transmembrane...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Protein Folding
• Share to Cystic Fibrosis
• Share to Cystic Fibrosis Transmembrane Conductance Regulator